dr mike davies

Carocell Bio is revolutionising the treatment of skin-related inflammatory conditions with its peptide-based, next-generation approach to promoting healthier skin.

Its pipeline of products, meant for topical skin application, is designed to interrupt the inflammatory cascade – potentially providing safer and novel therapeutic options to patients. This includes treating and preventing AD (eczema) and delaying skin ageing – a process strongly associated with inflammation.

Carocell Bio’s therapeutic pipeline consists of a number of small proteins (called “peptides”) that target an enzyme known as mitogen-activated protein kinase (MAPK). MAPK plays a key role in inflammation. These peptides have been specially formulated for topical use.


Find out more about our therapeutic peptides and how they can reduce inflammation to create healthier skin and also delay ageing of the skin


Find out the latest news and what’s happening currently at Carocell Bio. 


For further information and access to detailed documentation, please get in touch

Find out about our research and what we are currently doing